WARNING:
JavaScript is turned OFF. None of the links on this concept map will
work until it is reactivated.
If you need help turning JavaScript On, click here.
This Concept Map, created with IHMC CmapTools, has information related to: Colon Cancer efficacy endpoints v3, Adjuvant Agent instantiated by - Yes - No, New lesion identified by Organ specific lesion ID, Repeated concepts/instances throughout the CMAP are denoted by dotted outline, Patient Characteristics include Performance Status Rating, Colon Cancer Stage identified as 0 I II III IV, Objective Response Rate (ORR) correlates with Liver Metastases Resection Rate, Immunohistochemistry has outcome - Negative - Positive - Other, OVERALL RESPONSE have response options - CR - PR, Disease free survival (DFS) provides evidence for Disease recurrence, Tumor Response assesses Lesion, Non-measurable lesions evaluated by Existing lesion, Lesion identified by Anatomical region, -Complete Response (CR) -Partial Response (PR) -Not all evaluated -Stable disease (SD) -Progressive disease (PD) summarized into OVERALL RESPONSE, Tumor Assessment Endpoints include Objective Response Rate (ORR), Prior Therapy include Liver-directed therapy, Short axis for target lymph nodes measured in mm, OVERALL RESPONSE have response options -CR -PR, Concepts are denoted by solid round-edged rectangle, Systemic represneted by - Oxaliplatin - Irinotecan - Anti-VEGF antibody - Anti-EGFR - Regorafenib - FP - Other, Radiation of primary tumor instantiated by - Yes - No